Delivery Order SPE2DB20D9103-SPE2DB25FE7C3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,174.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The award was issued on September 15, 2025, with an ultimate completion date of October 6, 2025, under a firm fixed-price contract structure with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. This firm fixed-price delivery order is scheduled for ultimate completion by September 11, 2025, and was awarded on August 20, 2025, with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $18,502.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The delivery order carries a firm fixed-price structure with an ultimate completion date of September 19, 2025, and was processed without a set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $6,468.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $45,905 delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of May 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA valued at $500 million...
- The Defense Logistics Agency has awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200-unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100-unit vials. The award was issued on September 15, 2025, with an ultimate completion date of October 6, 2025, and represents a competitive procurement without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, issued under firm fixed-price terms with an ultimate completion date of September 4, 2025, represents a specific purchase order executed without set-aside designation. DMS Pharmaceutical Group, registered in the System for Award Management since...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- SPE2DB20D9103Indefinite Delivery Contract
- SPE2DB20D9103-SPE2DB25FE7C3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,017.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, was awarded without a set-aside designation. The award falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems nationwide. The company's contract portfolio with DLA demonstrates consistent success in securing pharmaceutical supply agreements covering diverse product categories including specialty medications, injections, and biologics. This delivery order for Botox, a specialized pharmaceutical product, exemplifies the company's role in providing essential medical supplies to support defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 4/24/25 |